Table 2.
Microarray analysis of selected genes of interest from a total of 995 genes that are at least twofold up- or down-regulated (p < 0.05; n = 3) across age namely E10–E20 when subjected to hypoxic treatment.
Category | p-Value | E10H/E10H | E14H/E10H | E17H/E10H | E20H/E10H | Description |
---|---|---|---|---|---|---|
Hypoxia induced | 0.003 | 1 | 2.22 | 2.26 | 2.40 | EROl-like. [Source: RefSeq; Acc: NM_015774] |
Growth factors | 0.028 | 1 | 0.85 | 0.87 | 0.45 | Vascular endothelial growth factor receptor 1 precursor (VEGFR 1; Tyrosine-protein kinase receptor FLT; FLT-1) [Source: Uniprot/SWISSPROT; Acc: P35969] |
0.045 | 1 | 1.59 | 0.93 | 2.08 | Vascular endothelial growth factor A precursor (VEGF-A; Vascular permeability factor, VPF). [Source: Uniprot/SWISSPROT; Acc: Q00731] | |
0.032 | 1 | 1.94 | 2.04 | 0.97 | Ephrin type-A receptor 7 precursor (Tyrosine-protein kinase receptor EHK-3) [Source: Uniprot/SWISSPROT; Acc: 061772] | |
0.047 | 1 | 0.70 | 0.43 | 0.59 | Transforming growth factor beta 4 precursor (TGF-beta 4; Left protein) [Source: Uniprot/SWISSPROT; Acc: O64280] | |
0.036 | 1 | 1.74 | 2.06 | 2.11 | Insulin-like growth factor II precursor (IGF-II). [Source: Uniprot/SWISSPROT; Acc: P09535] | |
Contractile proteins | 0.035 | 1 | 2.35 | 1.50 | 1.15 | Myosin X (Myo 10) |
0.021 | 1 | 3.01 | 4.43 | 5.84 | Myosin heavy chain, cardiac muscle alpha isoform (MyHC-alpha). [Source: Uniprot/SWISSPROT; Acc: Q02566] | |
0.001 | 1 | 1.05 | 1.14 | 2.34 | Actin, aortic smooth muscle (Alpha-actin 2). [Source: Uniprot/SWISSPROT; Acc: P03996] | |
0.035 | 1 | 3.00 | 4.86 | 6.72 | Actin. alpha cardiac. [Source: Uniprot/SWISSPROT: Acc: P04270] | |
0.011 | 1 | 1.05 | 2.97 | 2.52 | Troponin I, slow skeletal muscle (Troponin I, slow-twitch isoform). [Source: Uniprot/SWISSPROT; Acc: Q9WUZ5] | |
Transcription factors | 0.034 | 1 | 1.71 | 1.17 | 0.78 | Neurogenic locus notch homolog protein 4 precursor (Notch 4) [Source: Uniprot/SWISSPROT; Acc: P31695] |
Cytokines/chemokines | 0.034 | 1 | 1.28 | 2.12 | 1.70 | Interleukin-4 induced protein 1 precursor (FIG-1 protein; mFIG1). [Source: Uniprot/SWISSPROT: Acc: O09046] |
0.035 | 1 | 0.42 | 0.44 | 0.60 | Interleukin-6 precursor (IL-6; Interleukin HP-1; B-cell hybridoma growth factor). [Source: Uniprot/SWISSPROT; Acc: P08505] | |
Other proteins | 0.011 | 1 | 0.75 | 1.19 | 2.44 | CYR61 protein precursor (Cysteine-rich, angiogenic inducer, 61 (Insulin-like growth factor-binding protein 10; 3CH61). [Source: Uniprot/SWISSPROT; Acc: P18406] |
0.033 | 1 | 0.74 | 0.86 | 1.50 | Myocyte-specific enhancer factor 2A. [Source: Uniprot/SWISSPROT; Acc: Q60929] | |
0.029 | 1 | 0.95 | 0.67 | 0.47 | Myocardin (SRF cofactor protein; Basic SAP coiled-coil transcription activator 2). [Source: Uniprot/SWISSPROT; Acc: Q8VIM5] | |
0.036 | 1 | 2.73 | 2.74 | 1.74 | Semaphorin 6A precursor (Semaphorin VIA; SEMA6A-1; Semaphorin Q; Sema Q). [Source: Uniprot/SWISSPROT; Acc: 035464] |
Fold changes across all time points are normalized to E10H.